As a follow up to our workshop in Bar Harbor (Oct 2016), PSCP had the pleasuer of hosting and international delegation to discuss the “Significance of Genetic Variants for the use of Pluripotent Stem Cells in Regenerative Medicine” in Sheffield UK in October 2017.
Received for promoting interdisciplinary team science across the regenerative medicine community, key to the ethos of the UKRMP, this award recognised Zoe’s proactive and creative research leadership, making the most of developing and implementing new methods and opportunities.
The EBiSC consortium invites you to the Workshop “Scalability of the iPSC technology for future drug discovery & therapy” on 2-3 November 2017 at Fraunhofer-Forum in Berlin. The workshop aims at disseminating the learning from the establishment of the European Bank for induced Pluripotent Stem Cells (www.ebisc.eu) and address perspectives on stem cell applications over the next five years.
The UK Stem Cell Bank (UKSCB) at the National Institute for Biological Standards and Control (NIBSC) is releasing its first stem cell lines suitable for development into novel cell-based medicines to researchers wishing to bring new and innovative therapies to clinical trial.
The stem cell lines are produced and quality-controlled under European regulation and are therefore suitable for use as starting materials in manufacturing therapies for clinical trials, saving researchers precious time and effort.